NEL Weight Management Service for Tirzepatide go-live 1/12/25 – limited capacity

From 1st December 2025 NEL GPs will be able to refer eligible patients for weight management to access tirzepatide (Mounjaro) via the Barts Health Specialist Weight Management Service (SWMS) at the Royal London Hospital. 

From December 2025, eligible patients can be referred as per the NEL Weight Management Clinical Policy, via eRS to the Barts Health Service via Advice & Referral.  Please refer to the NEL policy regarding eligibility prior to any referrals- you can find the NEL Weight Management Clinical Policy here. Please note that our local Clinical Policy aligns with national guidance for access to Tirzepatide on the NHS at this time.

Please be aware that there will be limited capacity in the short term while the service expands and the SWMS team will clinically prioritise referrals received to ensure those with highest need are seen earlier. There will be an update regarding Homerton Hospital referrals in due course, pending final governance processes.